SCG Cell Therapy Announces U.S FDA Clearance of Investigational New Drug Application for SCG101, SCG’s Novel TCR-T Cell Therapy For Hepatitis B-related Liver Cancers
Singapore-based SCG Cell Therapy Pte Ltd ("SCG") announced that U.S. Food and Drug Administration (FDA) has cleared the Investigational New...
